Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4 Delta 30 increases viral susceptibility to type I interferon

作者：Bustos Arriaga Jose^*; Gromowski Gregory D; Tsetsarkin Konstantin A; Firestone Cai Yen; Castro Jimenez Tannya; Pletnev Alexander G; Cedillo Barron Leticia; Whitehead Stephen S

来源：Vaccine, 2018, 36(24): 3460-3467.

DOI：10.1016/j.vaccine.2018.04.087

• Dengue
• sfRNA
• Innate immunity
• Vaccine candidate

The NIH has developed live attenuated dengue virus (DENV) vaccine candidates by deletion of 30 nucleotides (Delta 30) from the untranslated region of the viral genome. Although this attenuation strategy has proven to be effective in generating safe and immunogenic vaccine strains, the molecular mechanism of attenuation is largely unknown. To examine the mediators of the observed attenuation phenotype, differences in translation efficiency, genome replication, cytotoxicity, and type I interferon susceptibility were compared between wild type parental DENV and DENV Delta 30 attenuated vaccine candidates. We observed that decreased accumulation of subgenomic RNA (sfRNA) from the vaccine candidates in infected human cells causes increased type I IFN susceptibility and propose this as one of the of attenuation mechanisms produced by the 3' UTR Delta 30 mutation.

• 出版日期2018-6-7
• 单位NIH